Sort by
Refine Your Search
-
Listed
-
Employer
-
Field
-
The Novo Nordisk Foundation has established a world-leading interdisciplinary research center to develop knowledge and technology for capturing and recycling carbon dioxide. The center is based
-
interactions, experience and expertise in psychometrics and scale development is highly valued. The planned starting date is July 1, 2026, or as soon as possible thereafter. The successful candidate will work as
-
The Novo Nordisk Foundation has established a world-leading interdisciplinary research center to develop knowledge and technology for capturing and recycling carbon dioxide. The center is based
-
workplace for all and to foster a culture in which each individual has opportunities to thrive, achieve and develop. We view equality and diversity as assets, and we welcome all applicants. Research
-
imaging, deep proteomics, metabolomics, metaproteomics, and machine learning (ML) approaches to develop diagnostic classifiers, spatial tissue atlases, and identify potential therapeutic targets
-
for a two-year postdoc, ideally starting August 1st, 2026. The position will encompass the ethnographic study of wind energy infrastructure development in Norway. The postdoc is part of the Sapere Aude
-
translate cutting-edge concepts into experimentally validated devices. By joining us, you will operate at the absolute forefront of heterogeneous photonic integration, develop high-performance nonlinear and
-
Nordisk NERD grant, which will fund our research activities in quantum materials for the next 7 years. What we offer The successful candidate is offered: access to a well-developed research infrastructure
-
) micro-CT imaging of breast cancer combining cutting-edge imaging technology with clinical pathology to develop quantitative 3D imaging biomarkers that bridge high-resolution micro-CT and histology. Our
-
imaging, deep proteomics, metabolomics, metaproteomics, and machine learning (ML) approaches to develop diagnostic classifiers, spatial tissue atlases, and identify potential therapeutic targets